Back to search

Article

Mid-pregnancy placental transcriptome in a model of placental insufficiency with and without novel intervention

2024-06-09

Abstract excerpt

Fetal growth restriction (FGR) affects between 5-10% of all live births. Placental insufficiency is a leading cause of FGR, resulting in reduced nutrient and oxygen delivery to the fetus. Currently, there are no effective in utero treatment options for FGR, or placental insufficiency. We have developed a gene therapy to deliver, via a non-viral nanoparticle, human insulin-like 1 growth factor ( hIGF1 ) to the pl...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
64acfaa1-2d2d-53b6-8577-dfc102fb1232
DOI
10.1101/2024.06.05.597621
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Mid-pregnancy placental transcriptome in a model of placental insufficiency with and without novel interventionDOI 10.1101/2024.06.05.597621
Maternal-fetal interfaces transcriptome changes associated with placental insufficiency and a novel gene therapy interventionSemantic proximity
Placental Nanoparticle-mediated IGF1 Gene Therapy Corrects Fetal Growth Restriction in a Guinea Pig ModelSemantic proximity
Nanoparticle‐mediated transgene expression of insulin‐like growth factor 1 in the growth restricted guinea pig placenta increases placenta nutrient transporter expression and fetal glucose concentrationsSemantic proximity
Placental <i>hIGF1</i> nanoparticle gene therapy in guinea pigs ameliorates fetal growth restriction-associated changes in hepatic lipid and glucose metabolism-related signaling pathways in a fetal sex-specific mannerSemantic proximity
Nanoparticle-mediated transgene expression of <i>insulin-like growth factor 1</i> in the growth restricted guinea pig placenta increases placenta nutrient transporter expression and fetal glucose concentrationsSemantic proximity
Placental nanoparticle gene therapy normalizes gene expression changes in the fetal liver associated with fetal growth restriction in a fetal sex-specific mannerSemantic proximity
Placental treatment with <i>insulin-like growth factor 1</i> via nanoparticle differentially impacts vascular remodeling factors in guinea pig sub-placenta/deciduaSemantic proximity
Placenta <i>hIGF1</i> nanoparticle treatment in guinea pigs mitigates fetal sex dependent FGR-associated effects on kidney structure and blood pressure-related signaling pathwaysSemantic proximity
Placental Gene Therapy for Fetal Growth Restriction and Preeclampsia: Preclinical Studies and Prospects for Clinical ApplicationSemantic proximity
Placenta Transcriptome Profiling in Intrauterine Growth Restriction (IUGR)Semantic proximity
RNA-Seq reveals changes in human placental metabolism, transport and endocrinology across the first–second trimester transitionSemantic proximity
Identifying target sites for placental therapeutics through the comparison of normal term pregnancies and intrauterine growth restricted proteomesSemantic proximity
Select a neighboring publication to make it the new centre.